Prospects of malaria vaccination in Nigeria: Anticipated challenges and lessons from previous vaccination campaigns
Open Access
- 17 August 2022
- journal article
- editorial
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 81, 104385
Abstract
Malaria is a severe public health issue in Nigeria, with higher morbidity and mortality rates than any other country. An estimated 100 million malaria cases and over 300,000 deaths are recorded yearly in Nigeria. Vaccination is an effective strategy in combating and eliminating infectious diseases such as malaria, thus, the deployment of a prospective malaria vaccine in Nigeria offers hope to the country's health sector. However, vaccination programmes face challenges, particularly in communities that are difficult to reach geographically or culturally, and these obstacles can only be overcome through continued international, national, and individual commitment. There is a need for expanded and continuous public health information, education, and communication particularly on contemporary health issues such as malaria and vaccination hesitancy. This will enable easier implementation and compliance to strategies for the sustainable control and eventual elimination of malaria. This article highlights some of the lessons learned from previous vaccination programs in Nigeria and how the insight gotten can be pivotal in ensuring the success of a prospective malaria vaccination programme in Nigeria.Keywords
This publication has 15 references indexed in Scilit:
- When it is available, will we take it? Social media users’ perception of hypothetical COVID-19 vaccine in NigeriaPan African Medical Journal, 2021
- Covid-19: Keep essential malaria services going during pandemic, urges WHO2020
- RTS,S malaria vaccine pilots in three African countriesThe Lancet, 2019
- Global investment targets for malaria control and elimination between 2016 and 2030BMJ Global Health, 2017
- Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African SitesPLOS Medicine, 2014
- The path of malaria vaccine development: challenges and perspectivesJournal of Internal Medicine, 2014
- Fighting Against Age Discrimination in Clinical TrialsJournal of the American Geriatrics Society, 2010
- Trends affecting the future of vaccine development and delivery: The role of demographics, regulatory science, the anti-vaccine movement, and vaccinomicsVaccine, 2009
- Risks for preterm delivery and low birth weight are independently increased by severity of maternal anaemia.2009
- Road Map for Polio Eradication–Establishing the Link with Millennium Development Goal No. 4 for Child SurvivalJapanese Journal of Infectious Diseases, 2008